Invention Grant
US08759006B2 PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia
有权
PSCA：前列腺干细胞抗原和区分雄激素受体阴性前列腺癌与良性前列腺增生
- Patent Title: PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia
- Patent Title (中): PSCA：前列腺干细胞抗原和区分雄激素受体阴性前列腺癌与良性前列腺增生
-
Application No.: US12169561Application Date: 2008-07-08
-
Publication No.: US08759006B2Publication Date: 2014-06-24
- Inventor: Robert E. Reiter , Owen N. Witte
- Applicant: Robert E. Reiter , Owen N. Witte
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California
- Current Assignee: The Regents of the University of California
- Current Assignee Address: US CA Oakland
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/567 ; G01N33/574
Abstract:
The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.
Public/Granted literature
- US20090104631A1 PSCA: PROSTATE STEM CELL ANTIGEN AND USES THEREOF Public/Granted day:2009-04-23
Information query
IPC分类:
